Pune, India, November 2018/MRFR Press Release/- Market Research Future has published a half-cooked research report on the Global Dermal Fillers Market.
There is a growing market for facial injectables - popularly known as dermal fillers in various parts of the world. The latest study conducted by Market Research Future (MRFR) projects that the global market for dermal fillers will surpass a valuation of US$ 10000 million by the year 2023, exhibiting a compound annual growth rate of 12.5% between 2017 and 2023. Increased acceptance of such products is creating lucrative opportunities for market players. The growing demand for facial aesthetics across the globe is a major force driving the growth of the global dermal fillers market. More and more people are opting for cosmetic procedures to maintain a youthful look. As the standard of living rises around the world, beauty enhancing services including dermal filler procedures become more popular.
There are different patient groups for dermal fillers, though, middle-aged and aged individuals are identified as the primary clients of aesthetic brands operating in the global dermal fillers market. This is because dermal fillers effectively reduce skin lines and wrinkles, thus helping in facial rejuvenation. It is also observed that the number of female clients is significantly higher than male clients. Nearly, 91% of facial injectable procedures are performed on women. At the same time, a considerable rise in popularity of such procedures among the male population is noticed of late. Advances in surgical technology have made such procedure safer and more effective than ever-before. However, there are no complete assurance of zero side-effects, which remains a key area of concern. Furthermore, high cost of surgery and regulatory norms continue to pose the other formidable challenges for the market.
Global Dermal Fillers Market: Segmental Analysis
MRFR’s report includes a descriptive segmental analysis of dermal fillers market based on types and application. By types, the market has been segmented into botulinum toxin, hyaluronic acid, polymers & particles and collagen. Among these, the botulinum toxin segment is likely to remain the most profitable segment. The segment is expected to reach a market valuation in excess of US$ 4600 by 2023-end. Meanwhile, the hyaluronic acid segment is projected to record the fastest growth rate during the assessment period.
By application, the market has been segmented into lip treatments, facial line correction treatment, face-lift and others. In 2016, the facial line correction treatment segment commanded the largest market share and is expected to reach a valuation of over US$ 4300 Mn by the year 2023. The face-lift segment is also expected to remain highly attractive in 2018 and beyond. The segment is expected to capture a robust CAGR of 12.8% between 2017 and 2023.
Global Dermal Fillers Market:
The market has been covered across regions such as North America, Latin America, the Middle East & Africa (MEA) Europe and Asia Pacific (APAC). The Americas region is expected to remain a lucrative market for dermal fillers throughout the assessment period. In 2016, North America and Latin America collectively accounted for more than one-third share of the market. Americas is followed by Europe, demand for facial aesthetics is high in many of the European countries, which makes the region an important market for dermal fillers. The Europe dermal fillers market is expected to witness a double-digit CAGR during the forecast period. Meanwhile, the dermal fillers market is Asia Pacific is expected witness the highest CAGR during the assessment period. This can be attributed to factors such as rising per-capita income, increased acceptance of cosmetic procedures in APAC countries and availability of more options of facial injectables to select from.
Access Report Details @ https://www.marketresearchfuture.com/reports/dermal-fillers-market-3893
Global Dermal Fillers Market: Competitive Landscape
MRFR in its report has profiled some of the key players operating in the global market for dermal fillers, which include GALDERMA, Integra Lifesciences, Sinclair Pharma, ALLERGAN, Teoxane Laboratories, Dr. Korman Laboratories and Merz Pharma.